Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ramucirumab in Indian Patients with Advanced Gastric Cancer-Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit?
Ramaswamy A, Bajaj K, Talwar V, Prabhash K, Batra U, Dhabhar B, Sharma M, Ghadyalpatil N, Ct S, Goyal G, Muzamil J, Bhatt A, Jain P, Ranade A, Kamath M, Gawande JP, Thippeswamy R, Mirani J, Reddy N, Ganguly S, Mishra SK, Madabhavi I, Hp S, Panda SS, Patil S, Bhargava P, Ostwal V. Ramaswamy A, et al. Among authors: sharma m. South Asian J Cancer. 2021 Sep 4;11(1):24-30. doi: 10.1055/s-0041-1728980. eCollection 2022 Jan. South Asian J Cancer. 2021. PMID: 35833042 Free PMC article.
Good response to erlotinib in a patient after progression on osimertinib: A rare case of spatiotemporal T790M heterogeneity in a patient with epidermal growth factor receptor-mutant nonsmall cell lung cancer.
Babu Koyyala VP, Batra U, Jain P, Sharma M, Goyal P, Domadia K, Botra S. Babu Koyyala VP, et al. Among authors: sharma m. South Asian J Cancer. 2017 Oct-Dec;6(4):179. doi: 10.4103/sajc.sajc_209_17. South Asian J Cancer. 2017. PMID: 29404300 Free PMC article. No abstract available.
Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital.
Babu Koyyala VP, Batra U, Jain P, Sharma M, Goyal P, Medisetty P, Jajodia A, Maheshwari UD. Babu Koyyala VP, et al. Among authors: sharma m. Lung India. 2018 Sep-Oct;35(5):390-394. doi: 10.4103/lungindia.lungindia_451_17. Lung India. 2018. PMID: 30168457 Free PMC article.
Severe hypoglycemia with trastuzumab: An unseen adverse event.
Amrith BP, Jain P, Chaudhari KA, Sharma M, Batra U. Amrith BP, et al. Among authors: sharma m. South Asian J Cancer. 2019 Jul-Sep;8(3):149. doi: 10.4103/sajc.sajc_400_18. South Asian J Cancer. 2019. PMID: 31489285 Free PMC article. No abstract available.
Malfeasance of KRAS mutations in carcinogenesis.
Tripathi R, Nathany S, Mehta A, Batra U, Mattoo S, Sharma M. Tripathi R, et al. Among authors: sharma m. Clin Exp Med. 2021 Aug;21(3):439-445. doi: 10.1007/s10238-021-00694-z. Epub 2021 Mar 12. Clin Exp Med. 2021. PMID: 33709341
9,598 results